Strokes are a leading cause of death in the U.S., with nearly 800,000 people experiencing one every year. On average, a stroke occurs every 40 seconds in the country. These numbers are jarring and ...

Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) are at risk for recurrent stroke. Low factor XI levels are associated with a reduced risk of ischemic stroke.

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

There are rumors alleging that Donald Trump experienced a mini-stroke, or TIA. While the rumor can't be proven, there is still plenty of research around TIAs.

In OCEANIC-STROKE, patients who received asundexian after a non-cardioembolic ischemic stroke or high-risk transient ischemic attack were significantly less likely to suffer a secondary stroke ...

Because of the trust you have with your patients, you are in a unique position to notice, evaluate, and act on neurologic and other conditions your patients experience. As you are interacting with ...

Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...